Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
6.45
Dollar change
+0.21
Percentage change
3.37
%
IndexRUT P/E8.95 EPS (ttm)0.72 Insider Own17.32% Shs Outstand54.54M Perf Week-5.98%
Market Cap364.20M Forward P/E- EPS next Y-1.54 Insider Trans-0.06% Shs Float45.16M Perf Month-11.40%
Income25.88M PEG- EPS next Q-0.36 Inst Own64.70% Short Float5.41% Perf Quarter4.20%
Sales163.78M P/S2.22 EPS this Y-130.92% Inst Trans-4.79% Short Ratio4.09 Perf Half Y-23.40%
Book/sh6.06 P/B1.07 EPS next Y-67.72% ROA7.18% Short Interest2.44M Perf Year-15.24%
Cash/sh6.12 P/C1.05 EPS next 5Y- ROE10.22% 52W Range5.19 - 11.72 Perf YTD-23.58%
Dividend Est.- P/FCF- EPS past 5Y- ROI7.02% 52W High-44.97% Beta0.90
Dividend TTM- Quick Ratio8.45 Sales past 5Y355.29% Gross Margin96.91% 52W Low24.28% ATR (14)0.43
Dividend Ex-Date- Current Ratio8.45 EPS Y/Y TTM-43.86% Oper. Margin5.54% RSI (14)51.85 Volatility6.12% 6.24%
Employees162 Debt/Eq0.14 Sales Y/Y TTM3.40% Profit Margin15.80% Recom1.09 Target Price17.10
Option/ShortYes / Yes LT Debt/Eq0.12 EPS Q/Q73.53% Payout0.00% Rel Volume0.61 Prev Close6.24
Sales Surprise110.46% EPS Surprise64.03% Sales Q/Q433.79% EarningsNov 12 AMC Avg Volume597.65K Price6.45
SMA204.74% SMA50-1.82% SMA200-16.30% Trades Volume362,831 Change3.37%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Initiated Citigroup Buy $12
Nov-29-24Resumed Wedbush Outperform $7 → $11
Oct-16-24Initiated Leerink Partners Outperform $15
Mar-26-24Initiated Guggenheim Buy $22
Mar-19-24Initiated H.C. Wainwright Buy $30
Mar-07-24Initiated Citigroup Buy $16
Jan-02-24Upgrade Wells Fargo Equal Weight → Overweight $14
May-10-23Initiated Truist Buy $18
Mar-10-23Initiated Oppenheimer Outperform $14
Oct-07-21Upgrade Robert W. Baird Neutral → Outperform $6 → $9
Dec-03-24 09:55AM
Nov-30-24 06:55AM
Nov-20-24 07:00AM
Nov-13-24 08:37AM
02:18AM
05:20PM Loading…
Nov-12-24 05:20PM
04:19PM
04:01PM
Nov-06-24 07:00AM
Nov-05-24 07:00AM
Oct-28-24 10:01AM
Oct-07-24 05:16AM
Sep-16-24 07:00AM
Sep-05-24 08:00AM
Aug-29-24 04:01PM
07:00AM Loading…
07:00AM
Aug-07-24 07:00AM
Aug-06-24 05:15PM
04:11PM
04:01PM
Jul-30-24 07:00AM
Jul-23-24 04:01PM
Jul-09-24 04:01PM
Jun-13-24 04:01PM
07:00AM
May-16-24 07:00AM
May-14-24 08:16AM
06:27AM
03:03AM
May-13-24 08:56PM
05:10PM Loading…
05:10PM
04:09PM
04:01PM
May-08-24 06:00AM
May-06-24 07:00AM
Apr-22-24 04:30PM
Apr-16-24 07:00AM
Mar-30-24 03:00AM
Mar-26-24 04:01PM
Mar-13-24 07:00AM
Mar-09-24 01:09PM
Feb-29-24 11:09AM
09:54AM
Feb-28-24 04:41PM
04:32PM
04:01PM
Feb-26-24 07:00AM
Feb-21-24 07:00AM
Feb-20-24 07:00AM
Feb-07-24 07:00AM
Jan-11-24 10:09PM
Jan-04-24 10:45PM
04:14PM
Jan-03-24 11:15AM
07:00AM
Jan-02-24 04:07PM
01:51PM
10:46AM
07:36AM
07:14AM
07:14AM
07:09AM
07:00AM
Dec-17-23 12:03PM
Dec-08-23 10:13AM
Dec-07-23 06:10AM
Dec-06-23 07:00AM
Nov-07-23 10:16AM
Nov-06-23 05:22PM
04:17PM
04:01PM
Oct-30-23 07:00AM
Sep-25-23 07:00AM
Sep-07-23 04:01PM
Aug-30-23 07:00AM
Aug-22-23 08:14AM
Aug-08-23 04:01PM
Aug-07-23 08:00AM
Aug-03-23 08:25AM
07:17AM
07:00AM
Aug-02-23 07:00AM
Jul-27-23 07:00AM
Jul-14-23 05:40AM
Jul-11-23 08:53PM
04:01PM
Jul-10-23 08:00AM
Jun-21-23 04:49AM
Jun-15-23 06:30AM
Jun-01-23 07:52PM
07:00AM
May-25-23 12:29PM
May-18-23 06:00AM
May-09-23 08:35AM
07:37AM
07:00AM
06:55AM
May-05-23 06:08AM
May-03-23 10:25PM
May-02-23 04:30PM
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fahey Sandell JacquelynChief Legal OfficerOct 02 '24Sale5.825,99934,91486,001Oct 03 04:43 PM
Fahey Sandell JacquelynOfficerOct 02 '24Proposed Sale5.825,99934,920Oct 02 04:26 PM
Swartz RobinChief Operating OfficerApr 02 '24Sale9.881,35713,407117,004Apr 03 04:13 PM
Sandrock AlfredPresident and CEOApr 02 '24Sale9.8612,115119,454322,839Apr 03 04:10 PM
Swartz RobinChief Operating OfficerFeb 21 '24Sale7.453,96629,547118,361Feb 22 04:36 PM
Sandrock AlfredPresident and CEOFeb 21 '24Sale7.4613,03397,226334,954Feb 22 04:34 PM
PFREUNDSCHUH PETER P.Chief Financial OfficerFeb 21 '24Sale7.463,76428,079175,669Feb 22 04:32 PM
Carter Todd AlfredChief Scientific OfficerFeb 21 '24Sale7.473,36525,13787,627Feb 22 04:30 PM
Carter Todd AlfredChief Scientific OfficerFeb 20 '24Sale7.686024,62390,992Feb 22 04:30 PM
Swartz RobinChief Operating OfficerJan 17 '24Sale7.152,54318,18272,327Jan 19 04:34 PM
Carter Todd AlfredChief Scientific OfficerJan 17 '24Sale7.181,2669,09053,094Jan 19 04:32 PM